The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis

Japanese Journal of Ophthalmology

Volumn 46, Issue 4, 2002, Pages 370-376

  Inoue, Tomoyuki ^a   Inoue, Yoshitsugu ^a   Nakamura, Takao ^a   Yoshida, Atsushi ^a   Inoue, Yumiko ^a   Tano, Yasuo ^a   Shimomura, Yoshikazu ^b   Fujisawa, Yukio ^c   Aono, Aki ^c   Hayashi, Kozaburo ^d  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^d KOBE INSTITUTE OF HEALTH   (Japan)

Author keywords

DNA vaccination; gD IL 2; Herpetic keratitis; Murine model; Peptide vaccination

Indexed keywords

GLYCOPROTEIN D; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; PLASMID DNA;

ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PURIFICATION; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-2; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT FUSION PROTEINS; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0036661711     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(02)00501-4     Document Type: Article

References (21)

1. Thomas J., Rouse B.T. Immunopathogenesis of herpetic ocular disease. Immunol Res. 16:1997;375-386.
2. Meignier B. Vaccination against herpes simplex virus infection. Roizman B. The human herpes viruses 4. 1985;265-296 Plenum Press, New York.
3. Spear P.G. Membrane proteins specified by herpes simplex viruses I. identification of four glycoprotein precursors and their products in type 1-infected cells J Virol. 17:1976;991-1008.
4. Chan W.L. Protective immunization of mice with specific HSV-1 glycoproteins. Immunology. 49:1983;343-352.
5. Cohen G.H., Dietzschold B., de Leon M.P.et al. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol. 49:1984;102-108.
6. Schrier R.D., Pizer L.I., Moorhead J.W. Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. J Immunol. 130:1983;1413-1417.
7. Kino Y., Eto T., Nishiyama K., Ohtomo N., Mori R. Immunogenicity of purified glycoprotein gB of herpes simplex virus. Arch Virol. 89:1986;69-80.
8. Long D., Madara T.J., Ponce de Leon M.et al. Glycoprotein D protects mice against lethal change with herpes simplex virus type 1 and 2. Infect Immun. 37:1984;761-764.
9. Inoue Y., Ohashi Y., Shimomura Y.et al. Herpes simplex virus glycoprotein D. protective immunity against murine herpetic keratitis Invest Ophthalmol Vis Sci. 31:1990;411-418.
10. Hinuma S., Hazama M., Mayumi A., Fujisawa Y. A novel strategy for converting recombinant viral protein into high immunogenic antigen. FEBS. 288:1991;138-142.
11. Hazama M., Mayumi-Aono A., Asakawa N.et al. Adjuvant- independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2. Vaccine. 11:1993;629-636.
12. Wolff J.A., Malone R.W., Williams P.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
13. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
14. Wang B., Ugen K.E., Srikantan V.et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci. 90:1993;4156-4160.
15. Ulmer J.B., Donnelly J.J., Parker S.E.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
16. McCarthy M. DNA vaccination. a direct line to the immune system Lancet. 348:1996;1232.
17. Siegel S. The case of κ independent samples. Siegel S. Nonparametric statistics for the behavioral sciences (International student ed.). 1956;174-194 Kogakusha (McGraw-Hill Book Company), Tokyo.
18. Rouse B.T., Miller L.S., Turtinen L., Moore R.N. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin-2. J Immunol. 134:1985;926-930.
19. Weinberg A., Konrad M., Merigan T.C. Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs. J Virol. 61:1987;2120-2127.
20. Nesburn A.B., Slanina S., Burke R.L.et al. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits. J Virol. 72:1998;7715-7721.
21. Inoue T., Inoue Y., Nakamura T.et al. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci. 41:2000;4209-4215.